CTRI/2014/09/005070
Completed
未知
Intravitreal Bevacizumab Versus Triamcinolone for Treatment of Diabetic Macular Edema-- One Year Results
ethradhama Superspeciality Eye Hospita0 sites15 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- DIABETES MELLITUS
- Sponsor
- ethradhama Superspeciality Eye Hospita
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All Patients with clinically significant macular oedema (according to ETDRS study) with systemic diabetis mellitus of \> 3 months duration.
- •Patients were required to have a baseline CRT of at least 300 um and BCVA of 20/25 to 20/400 Snellen equivalent in the study eye.
- •Patients with HbA1c controlled at less than 8\.0% at the beginning and during the study duration.
Exclusion Criteria
- •Patients with bilateral macular oedema, with retinal thickness difference between two eyes of \>100um.
- •Patient with history of
- •Macular Laser Photocoagulation
- •Intravitreal Injection Therapy
- •Active Proliferative Diabetic Retinopathy (PDRP) With Necessity Of Panretinal Laser Treatment
- •Panretinal Laser Treatment Within The Past 3 Months
- •Previous vitreous surgery
- •IHD \& CVA
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Comparison of Intravitreal Bevacizumab and Triamcinolone with Placebo in Acute Nonarteritic Anterior Ischemic Optic NeuropathyAnterior Ischemic of Optic Nerve.Disorders of optic nerve, not elsewhere classifiedIRCT1138901221180N13Ophthalmic Research Center16
Completed
Not Applicable
Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein OcclusionCentral Retinal Vein Occlusion With Macular EdemaNCT04812977Hayatabad Medical Complex30
Unknown
Phase 3
Effect of Intravitreal Bevacizumab on Clinically Significant Macular EdemaDiabetic Macular EdemaNCT00370669Shahid Beheshti University of Medical Sciences150
Completed
Not Applicable
Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularizatioJPRN-UMIN000008588Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele50
Completed
Phase 2
effect of Bevacizumab alone or in combination with 1 mg Triamcinolone for treatment of diabetic retina swellingDiabetic Macular Edema.Diabetic retinopathyIRCT2014080818733N1vice-chancellor for research-Tehran University of Medical Science50